PetMed Express, Inc. (PETS) — Analysis Summary
PetMed Express, Inc. (PETS) has a market cap of $27.32M with year-over-year revenue growth of -21.1%. Net margin stands at -32.0%. The stock trades at a P/E ratio of -0.9.
Key Takeaways
- Revenue changed -21.1% year-over-year
- Net margin of -32.0%
- P/E ratio of -0.9
Compared to other companies in the RETAIL-DRUG STORES AND PROPRIETARY STORES sector, PETS posted revenue growth of -21.1% and trades at a P/E of -0.9.
PetMed Express, Inc. (PETS)
PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Current ratio at 0.68x — current liabilities exceed current assets
Operating margin at -18.2% — material operating losses
The latest filing shows negative free cash flow.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Sector
RETAIL-DRUG STORES AND PROPRIETARY STORES
Employees
189
Headquarters
DELRAY BEACH, FL
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Annual Dividend/Share
$1.20
Dividend Yield
95.24%
Dividend History
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.